Skip to main content
Log in

Interaction of angiotensin-converting enzyme and apolipoprotein E gene polymorphisms in ischemic stroke involving large-vessel disease

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

A relationship between apolipoprotein E (Apo E) genotype and angiotensin-converting enzyme (ACE) insertion-deletion (Ins-Del) mutation and stroke was suggested. We investigated the association of Apo E4 and ACE Ins/Del genotypes with stroke risk and changes in serum lipids in 228 consecutive Tunisian stroke patients, and 323 age-and gender-matched controls. Comparable frequencies of ACE Ins/Del alleles were seen between patients and controls. The prevalence of Apo ε3 allele and Apo E3/E3 were lower (P < 0.001), while the frequency of Apo ε4 allele and ε4-containing genotypes (E3/E4 and E4/E4) were elevated (P < 0.001) among patients. Higher proportion of Apo E4-carrying + ACE Del/Del positive cases were seen in young (<50 years) patients (P = 0.012), and was associated with large vessel stroke (P = 0.035). Mean serum cholesterol, LDL, HDL, and triglycerides were comparable between E4-containing and no E4-containing and ACE Del/Del-positive patients. Apo E4 and ACE Del/Del genotype combination substantially increase stroke risk, supporting the notion that interactions of multiple gene variants influence stroke pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gao X, Yang H, ZhiPing T (2006) Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neurosci Lett 398:172–177

    Article  PubMed  CAS  Google Scholar 

  2. Hassan A, Markus HS (2000) Genetics and ischemic stroke. Brain 123:1784–1812

    Article  PubMed  Google Scholar 

  3. Ariyaratnam R, Casas JP, Whittaker J et al (2007) Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 4:e131

    Article  PubMed  CAS  Google Scholar 

  4. Banerjee I, Gupta V, Ganesh S (2007) Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 52:205–219

    Article  PubMed  CAS  Google Scholar 

  5. Liao D, Myers R, Hunt S et al (1997) Familial history of stroke and stroke risk: the Family Heart Study. Stroke 28:1908–1912

    PubMed  CAS  Google Scholar 

  6. Um JY, Kim HM, Park HS et al (2005) Candidate genes of cerebral infarction and traditional classification in Koreans with cerebral infarction. Int J Neurosci 115:743–756

    Article  PubMed  CAS  Google Scholar 

  7. Zhang JH, Kohara K, Yamamoto Y et al (2004) Genetic predisposition to neurological symptoms in lacunar infarction. Cerebrovasc Dis 17:273–279

    Article  PubMed  Google Scholar 

  8. Nakata Y, Katsuya T, Rakugi H et al (1997) Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens 10:1391–1395

    PubMed  CAS  Google Scholar 

  9. Slowik A, Turaj W, Dziedzic T et al (2004) DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology 63:359–361

    PubMed  CAS  Google Scholar 

  10. Um JY, Moon KS, Lee KM et al (2003) Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction. J Mol Neurosci 21:23–28

    Article  PubMed  CAS  Google Scholar 

  11. Szolnoki Z (2005) Evaluation of the interactions of common genetic mutations in stroke. Methods Mol Med 104:241–250

    PubMed  CAS  Google Scholar 

  12. Siest G, Pillot T, Regis-Bailly A et al (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 41:1068–1086

    PubMed  CAS  Google Scholar 

  13. Batalla A, Alvarez R, Reguero JR et al (2000) Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem 46:1910–1915

    PubMed  CAS  Google Scholar 

  14. Luc G, Bard J, Arveiler D (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb 14:1412–1419

    PubMed  CAS  Google Scholar 

  15. Karagiannis A, Balaska K, Tziomalos K et al (2004) Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke. Eur Neurol 51:148–152

    Article  PubMed  CAS  Google Scholar 

  16. Tuncer N, Tuglular S, Kilic G et al (2006) Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic stroke. J Clin Neurosci 13:224–227

    Article  PubMed  CAS  Google Scholar 

  17. O’Malley JP, Maslen CL, Illingworth DR (1998) Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia. Circulation 97:1780–1783

    PubMed  CAS  Google Scholar 

  18. Nickenig G, Jung O, Strehlow K et al (1997) Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol 272:H2701–H2707

    PubMed  CAS  Google Scholar 

  19. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM (2007) Renin-angiotensin system and cardiovascular risk. Lancet 369:1208–1219

    Article  PubMed  CAS  Google Scholar 

  20. Keidar S, Attias J, Heinrich R et al (1999) Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis 146:249–257

    Article  PubMed  CAS  Google Scholar 

  21. Bosse Y, Vohl MC, Dumont M et al (2002) Influence of the angiotensin-converting enzyme gene insertion/deletion polymorphism on lipoprotein/lipid response to gemfibrozil. Clin Genet 62:45–52

    Article  PubMed  CAS  Google Scholar 

  22. Ruland S, Gorelick PB (2003) Are cholesterol-lowering medications and anti-hypertensive agents preventing stroke in ways other than by controlling the risk factor? Curr Atheroscler Rep 5:38–43

    Article  PubMed  Google Scholar 

  23. Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433

    Article  PubMed  CAS  Google Scholar 

  24. Al-Khedhairy AA (2004) Apolipoprotein E polymorphism in Saudis. Mol Biol Rep 31: 257–260

    Article  PubMed  CAS  Google Scholar 

  25. Mahfouz RA, Sabbagh AS, Zahed LF et al (2006) Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population. Mol Biol Rep 33:145–149

    Article  PubMed  CAS  Google Scholar 

  26. Al-Bustan SA, Alnaqeeb MA, Annice BG et al (2005) Apolipoprotein E genotyping among the healthy Kuwaiti population. Hum Biol 77:487–498

    Article  PubMed  Google Scholar 

  27. Lahlali-Kacemi N, Bamou Y, Guedira A et al (2002) Polymorphisme de l’apolipoprotéine E dans une population marocaine: fréquence allélique et relation avec les paramètres lipidiques plasmatiques. Ann Biol Clin 60:73–78

    CAS  Google Scholar 

  28. Tikkanen MJ, Huttunen JK, Ehnholm C, Pietinen P (1990) Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 10:285–288

    PubMed  CAS  Google Scholar 

  29. Rigat B, Hubert C, Alhenc-Gelas F et al (1990) An insertion:deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest 86:1343–1346

    Article  PubMed  CAS  Google Scholar 

  30. Pera J, Slowik A, Dziedzic T et al (2006) ACE I/D polymorphism in different etiologies of ischemic stroke. Acta Neurol Scand 114:320–322

    Article  PubMed  CAS  Google Scholar 

  31. Bennouar N, Allami A, Laraqui A et al (2004) Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease. Ann Biol Clin (Paris) 62:295–304

    CAS  Google Scholar 

  32. Catto A, Carter AM, Barrett JH et al (1996) Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 27:435–440

    PubMed  CAS  Google Scholar 

  33. Hachinski V, Graffagnino C, Beaudry M et al (1996) Lipids and stroke: a paradox resolved. Arch Neurol 53:303–308

    PubMed  CAS  Google Scholar 

  34. del Ser T, Bornstein B, Barba R et al (2001) Relationship of angiotensin converting enzyme genotype with serum triglyceride concentration in stroke patients. Neurosci Lett 316:21–24

    Article  PubMed  Google Scholar 

  35. Okura Y, Hayashi K, Shingu T et al (2003) Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism. Coron Artery Dis 14:285–291

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wassim Y. Almawi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saidi, S., Zammiti, W., Slamia, L.B. et al. Interaction of angiotensin-converting enzyme and apolipoprotein E gene polymorphisms in ischemic stroke involving large-vessel disease. J Thromb Thrombolysis 27, 68–74 (2009). https://doi.org/10.1007/s11239-007-0165-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-007-0165-y

Keywords

Navigation